افزودن داروی جدید لیلی به Zepbound به افراد کمک کرد تا ۲۳ درصد از وزن خود را کاهش دهند. اما عوارض جانبی بیشتری داشت.

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.